Molecule Details
| InChIKey | SNFYYXUGUBUECJ-UHFFFAOYSA-N |
|---|---|
| Compound Name | Talarozole |
| Canonical SMILES | CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.36 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13083 |
|---|---|
| Drug Name | Talarozole |
| CAS Number | 201410-53-9 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Talarozole has been investigated for the treatment of Psoriasis and Cutaneous Inflammation. |
Categories: Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Thiazoles
Cross-references: BindingDB: 50253810 ChEBI: 102167 CHEMBL459505 ChemSpider: 7975653 PubChem:9799888 PubChem:347829208 Wikipedia: Talarozole
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q9NR63 | CYP26B1 | Homo sapiens | Human | PF00067 | 9.3 | IC50 | ChEMBL;BindingDB |
| O43174 | CYP26A1 | Homo sapiens | Human | PF00067 | 8.3 | IC50 | ChEMBL;BindingDB |
| P10632 | CYP2C8 | Homo sapiens | Human | PF00067 | 6.7 | IC50 | ChEMBL;BindingDB |
| P08684 | CYP3A4 | Homo sapiens | Human | PF00067 | 6.3 | IC50 | ChEMBL;BindingDB |
| P11712 | CYP2C9 | Homo sapiens | Human | PF00067 | 6.2 | IC50 | ChEMBL;BindingDB |